NCT02351180View on ClinicalTrials.gov

Inhaled Beclomethasone After Community-Acquired Respiratory Viral Infection in Lung Transplant Recipients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
Lung Transplant Infection
Interventions
DRUG

Inhaled beclomethasone

Inhaled steroid that may decrease airway inflammation and the risk of chronic rejection

DRUG

Placebo

Placebo will serve as a control treatment

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT02351180 - Inhaled Beclomethasone After Community-Acquired Respiratory Viral Infection in Lung Transplant Recipients | Biotech Hunter | Biotech Hunter